Rite Aid

Rite Aid Corporation

File:Rite Aid logo.svg Logo used since 2007
Company type	Public company
Industry	Pharmacy retail
Founded	September 1, 1962 (1962-09-01) in Scranton, Pennsylvania, United States
Founder	Alex Grass
Headquarters	Philadelphia, Pennsylvania , United States
Area served	United States (primarily East and West coasts)
Key people	John Standley (CEO as of 2010)
Products	Pharmacy products and services, retail merchandise
Number of employees	Over 112,800 (peak before 2008)
Parent	None
Website	www.riteaid.com

Rite Aid Corporation is a prominent American pharmacy chain with its main office located in Philadelphia, Pennsylvania. Established in 1962 by entrepreneur Alex Grass in Scranton, Pennsylvania, originally under the name Thrift D Discount Center, the company expanded to become the third-largest drugstore chain in the United States prior to its initial bankruptcy filing in 2023. At its peak, Rite Aid managed over 1,200 outlets across 15 states, primarily concentrated along the East and West coasts.

Following a rebranding to Rite Aid, the firm went public in 1968 and was subsequently listed on the New York Stock Exchange with the ticker symbol RAD. In 2022, it was ranked 148th on the Fortune 500 list. The company filed for Chapter 11 bankruptcy twice—in October 2023 and again in May 2025—citing heavy indebtedness, numerous opioid-related lawsuits, and unsuccessful attempts at restructuring.

1962–1989

The inception of Rite Aid traces back to September 1962 when founder Alex Grass opened the first store in Scranton, Pennsylvania. Initially operating as Thrift D Discount Center, the business expanded into five states by 1965 and transitioned to a public company under the Rite Aid name in 1968. The company secured a listing on the New York Stock Exchange by 1970.

By 1972, Rite Aid had grown to operate 267 stores across ten states. In June 1981, operations were disrupted by a ten-month strike initiated by Teamsters Local 182 over paid vacation benefits, which persisted until a National Labor Relations Board hearing in July 1982. Rite Aid achieved $1 billion in sales by 1983 and significantly increased its market presence through acquiring a chain of 420 stores along the East Coast, pushing its total locations beyond 2,000.

In October 1984, Rite Aid purchased the Federal Plaza building located in downtown Youngstown and entered the Michigan market through acquisitions including Muir Drug, Remes Drug, Lippert Pharmacy, and Herrlich Drug. Growth continued with the purchase of State Vitamin stores in Lansing during 1985 and further expansion into Ohio in 1987 by acquiring Cleveland-based Gray Drug, which encompassed Baltimore's Read's Drug Store. Following this deal, liquor licenses were transferred to Rite Aid in June 1988.

On April 10, 1989, Rite Aid further solidified its Ohio presence by acquiring Peoples Drug’s Lane Drug chain, adding 114 stores with annual revenues around $125 million. This acquisition reinforced Rite Aid’s leading position within Ohio’s pharmacy market.

1990–1999

Throughout the 1990s, Rite Aid pursued substantial growth via strategic acquisitions and alliances. Collaborating with Carl Paladino's Ellicott Development Co., the company expanded throughout upstate New York and ventured into Northern New England with the purchase of LaVerdiere's in 1994. That same year, it acquired twenty-four Hook's Drug Stores—some of which were sold to Perry Drug Stores—before acquiring Perry itself later that year. This move marked Rite Aid’s entry into Metro Detroit and broadened its Michigan footprint.

In 1995, Rite Aid sought to merge with Revco for $1.8 billion; however, antitrust concerns led to Federal Trade Commission intervention blocking the merger. Revco was ultimately acquired by CVS in 1997. Additionally, following the LaVerdiere’s acquisition in 1996, Rite Aid was compelled by the FTC to divest three stores.

The company aggressively expanded its West Coast operations by acquiring Thrifty PayLess for $2.3 billion in 1996, gaining control over Bi-Mart membership stores (which were sold off in 1997). Further acquisitions included Harco, Inc., and K&B, Inc. in 1997, extending Rite Aid’s reach into Gulf Coast markets.

During this decade, infrastructure investments included announcing a new distribution center in Maryland in 1997 that generated approximately 850 jobs. Nevertheless, late-1990s challenges emerged such as closing around 600 underperforming stores by 1999, postponing store openings due to escalating costs, and workforce reductions at distribution facilities.

Leadership transitions occurred amidst these difficulties: Chairman and CEO Martin Grass resigned in October 1999 amid growing debt linked to rapid expansion; Timothy J. Noonan succeeded him as CEO. Shareholders responded negatively as stock prices plummeted from $50 to below $10 per share. Leonard Green assumed chairmanship in November 1999. By December, Bob Miller—formerly affiliated with Albertson's and Kroger—was appointed chairman and CEO to guide the company away from bankruptcy risk.

Rite Aid restructured its executive leadership team by appointing Mary Sammons from Fred Meyer as president and COO; David Jessick took on chief administrative officer duties; John T. Standley became CFO—all signaling a strategic change aimed at enhancing financial health and business growth prospects. During this period of transition Deloitte & Touche replaced KPMG LLP as auditors.

2000–2009

In April 2000, Rite Aid obtained $1 billion in financing from Citibank, while J.P. Morgan converted $200 million of debt into equity at $5.50 per share. That same year, Rite Aid withdrew its pharmacy benefit manager, PCS Health Systems, from the market and subsequently sold it to Advance Paradigm for $1 billion in July 2000. By July 2001, the company enhanced its pharmacy complaint handling procedures in response to regulatory demands. After narrowly avoiding collapse in 1999, Rite Aid pursued expansion in 2004 and divested 1,260 Eckard locations to CVS. John Standley assumed the CEO role in 2003.

In August 2006, Rite Aid announced its acquisition of Jean Coutu Group’s U.S. subsidiaries—including 1,858 Eckerd and Brooks Pharmacy outlets—for $3.4 billion, granting Jean Coutu a 32% ownership stake in Rite Aid. This merger received shareholder and Federal Trade Commission approval by mid-2007 but required the divestiture of 23 stores. By September 2007, all Eckerd stores had been rebranded as Rite Aid, retiring the long-standing Eckerd brand. This transaction established Rite Aid as the dominant drugstore chain in the Eastern United States and the third largest nationwide, operating over 5,000 locations with a workforce exceeding 112,800 employees at its peak.

Post-merger, Rite Aid encountered integration difficulties; although revenues increased, these gains were offset by record financial losses. Between September 2007 and September 2008, the company’s stock price declined by more than 75%. By early 2008, redundant stores resulting from the acquisition were either consolidated or shuttered, favoring newer Eckerd sites featuring drive-through pharmacies and larger store formats. Rite Aid also maintained acceptance of JCPenney’s store credit card inherited from Eckerd.

In January 2008, Rite Aid withdrew from the Las Vegas market by closing all 28 locations and transferring prescription services to Walgreens, citing it as a non-core area; the final Nevada store closed in December 2023. In February 2009, select stores in San Francisco and eastern Idaho were sold to Walgreens; previously, Rite Aid had exited Columbus, Ohio through sales to CVS. Founder Alex Grass passed away in August 2009.

This decade was characterized by substantial growth driven by acquisitions and strategic asset sales, although profitability was hindered by integration expenses and intense competition within the retail pharmacy sector.

2010–2019

In June 2010, John Standley advanced from chief operating officer to CEO while former CEO Mary Sammons retained her position as chairperson. Ken Martindale, previously co-president at Pathmark, joined as chief operating officer. In 2013, Jean Coutu divested its entire ownership interest in Rite Aid.

Rite Aid expanded its service offerings in 2015 by acquiring EnvisionRx—a pharmacy benefit manager with subsidiaries including MedTrak, Connect Health Solutions, and Smith Premier Services.

On October 27, 2015, Walgreens Boots Alliance revealed plans to acquire Rite Aid for $9.4 billion with the objective of forming the largest U.S. pharmacy chain commanding a 46% market share. Walgreens initially planned to maintain the Rite Aid brand but left future branding strategies undecided.

Regulatory scrutiny delayed completion of the merger; to mitigate antitrust concerns, Rite Aid agreed in December 2016 to sell 865 stores to Fred’s for $950 million. The Federal Trade Commission demanded further store divestitures. In January 2017, Walgreens and Rite Aid renegotiated the deal price downward to $6.8 billion and postponed closing until July. The transaction faced resistance from the union representing approximately 6,000 Rite Aid workers.

On June 29, 2017, Walgreens abandoned plans for a full merger and instead proposed acquiring only 2,186 Rite Aid stores for $5.18 billion—less than half of the chain—resulting in Rite Aid’s withdrawal from the southeastern United States market. Following additional negotiations, Walgreens agreed in September 2017 to purchase 1,932 stores for $4.38 billion; this revised agreement received FTC approval.

The sale finalized on March 27, 2018, leaving Rite Aid with roughly 2,600 remaining locations. Distribution centers and inventory transfers commenced in September 2018; most acquired outlets were rebranded as Walgreens stores. Approximately 600 overlapping locations were closed during consolidation efforts.

On February 20, 2018, Albertsons announced intentions to merge with the remaining portion of Rite Aid in a transaction described as a merger of equals pending regulatory approvals. However, on August 8, 2018, Rite Aid declared that this agreement was terminated after failing to obtain shareholder approval.

2020–2025

In October 2020, Rite Aid completed the purchase of Bartell Drugs, a regional chain with 67 stores based in the Seattle area, for $95 million. This acquisition drew criticism due to challenges involving employee turnover and technical system disruptions.

By 2022, Rite Aid had moved its corporate headquarters from Camp Hill, Pennsylvania to Philadelphia. During the fiscal year 2022, Pennsylvania held the highest number of Rite Aid outlets at 494 locations, followed closely by California with 487 stores and New York with 281. On October 4, 2023, the company received a notice regarding possible removal from the New York Stock Exchange, initiating the delisting procedure on October 16, 2023.

First bankruptcy

On August 25, 2023, Rite Aid revealed intentions to seek Chapter 11 bankruptcy protection amid ongoing federal and state lawsuits tied to the opioid epidemic, which included plans to shutter up to 500 underperforming stores across the country. By October 2023, reports suggested the company was approaching bankruptcy status. Official Chapter 11 filings were submitted on October 15 by Rite Aid and related debtors in the United States District Court for the District of New Jersey. Following this filing, Rite Aid was removed from the New York Stock Exchange and began trading over-the-counter.

To maintain operations during bankruptcy proceedings, Rite Aid secured financing and debt restructuring agreements totaling $3.5 billion. By the end of 2023, about 500 stores had been closed, with another 92 stores targeted for closure or sale. The company cautioned investors that failure to reorganize within a year could result in liquidation. On October 18 alone, closures affected 154 stores while stock prices dropped to record lows.

Despite acquisitions dating back to 2007, subsidiaries such as The Jean Coutu Group (PJC) USA Inc. and Eckerd Corporation remain operational solely in name. In October 2023, Walgreens agreed to pay $192.5 million to resolve a lawsuit brought by Rite Aid investors alleging deceptive statements during Walgreens’ unsuccessful acquisition attempt in 2017.

In November, Rite Aid initiated legal action against the U.S. Department of Justice seeking to block opioid-related litigation accusing the company of ignoring warnings and issuing false prescriptions. A bankruptcy judge set March 1, 2024 as the deadline for reorganization efforts and warned that failure to meet this deadline could lead to liquidation. Store closures continued into late 2023 and early 2024, with plans announced to divest or close an additional 79 stores.

December saw Rite Aid enter court-supervised mediation involving opioid victims and creditors while also obtaining approval for a loan of roughly $200 million. The company reached a settlement with the Federal Trade Commission over allegations concerning improper use of AI-driven facial recognition technology; as part of this agreement, Rite Aid accepted a five-year prohibition on deploying such technology in its stores due to accusations of racial profiling. Additionally, in December, Rite Aid sold its Elixir insurance unit to MedImpact Healthcare Systems for approximately $575 million.

By mid-2024, Rite Aid prepared to cease operations at all Michigan locations and close its Waterford distribution center, resulting in nearly 200 layoffs. By August of that year, the company had either closed or announced plans to close a total of 778 stores—representing about 38% of its total footprint—including every Michigan store and nearly all sites in Ohio.

In September 2024, Rite Aid emerged from bankruptcy as a privately held entity with Matt Schroeder, previously CFO, elevated to CEO. This leadership transition signals a strategic focus on stabilizing post-bankruptcy operations by concentrating on key markets and streamlining its retail presence.

Second bankruptcy and shutdown

Following an unsuccessful attempt at restructuring, Rite Aid readied itself for a second Chapter 11 bankruptcy filing scheduled for April 4, 2025, while simultaneously considering the sale of assets. By April 22, the company revealed intentions to liquidate its operations in segments due to severe cash flow issues, anticipating that most outlets would be sold to the highest bidders and any unsold locations would be shut down.

On May 5, 2025, Rite Aid formally submitted its Chapter 11 bankruptcy petition once more, reporting assets and liabilities ranging from $1 billion to $10 billion. The company aimed to divest all assets and close all remaining pharmacies amidst ongoing financial difficulties caused by debt burdens, competitive pressures, and inflationary costs. After failing to obtain new financing, Rite Aid planned to terminate all employment and either sell or close its remaining 1,200 stores. The firm attributed its inability to maintain inventory levels to lenders withdrawing their support.

During May, the company announced the closure of 115 stores across ten states and established deadlines for bids on pharmaceutical assets by May 13 and on other assets by June 13. Gift cards, coupons, loyalty rewards, returns, and exchanges were honored only until June 5. On May 15, Rite Aid sold prescription records from more than 1,000 locations to competitors such as CVS Pharmacy—its largest purchaser—Walgreens, Albertsons, and Kroger. CVS acquired prescription files from 600 stores in 15 states plus an additional 64 locations in Idaho, Oregon, and Washington; this transaction received court approval on May 21.

Further closures ensued: an additional 27 stores were closed on May 16, bringing the total to 360 by May 27 after unsuccessful attempts to find buyers for certain prescription portfolios. Giant Eagle purchased prescription files from 78 stores located in Pennsylvania and Ohio on May 29. By June 6, over 800 Rite Aid outlets had ceased operations since October 2023; another 230 closures were reported by June 9.

On June 27, the court authorized Rite Aid to sell its Thrifty PayLess and Thrifty Ice Cream subsidiaries for $19.2 million to Hilrod Holdings, which is managed by Monster Beverage executives Hilton Schlosberg and Rodney Sacks. By July 6, plans were announced to close an additional 114 stores, pushing total closures beyond the 1,000 mark. As of July 2025, only 56 Rite Aid locations remained open with their long-term status uncertain.

Financial performance

In the second quarter of 2022, Rite Aid reported basic and diluted losses of $1.86 per share, a significant deterioration compared to a loss of $0.24 per share in earlier quarters.

Year	Revenue (in thousands USD$)	Net income (in thousands USD$)	Total assets (in thousands USD$)	Employees	Stores
2005	16,715,598	302,478	5,932,583	71,200	3,356
2006	17,163,044	1,273,006	6,988,371	70,200	3,323
2007	17,399,383	26,826	7,091,024	69,700	3,333
2008	24,326,846
11,488,023	112,800	5,059
2009	26,289,268
8,326,540	103,000	4,901
2010	25,669,117
8,049,911	97,500	4,780
2011	25,214,907
7,555,850	91,800	4,714
2012	26,121,222
7,264,385	90,000	4,667
2013	25,392,263	118,105	6,985,038	89,000	4,623
2014	25,526,413	249,414	6,860,672	89,000	4,587
2015	26,528,377	2,109,173	8.777.425	89.000	4.570
2016	30.736.657	165.465	11.277.010	90.000	4.561
2017	32.845.073	4.053	11.593.752	88.000	4.536
2018	21.528.968
8.989.327	60.800	2.550
2019	21.639.557
7.591.367	53.100	2.464
2020	21.928.390
2.451
2021	24.043.240	2.229
2022	24.568.260
2.102

Federal Trade Commission (FTC)

In 1998, the FTC imposed a $900,000 penalty on Rite Aid for failing to divest three retail locations in Maine and New Hampshire as mandated in 1994, a condition intended to address antitrust concerns linked to the LaVerdiere's acquisition.

Expired Product Sales

In 1999, investigations revealed that Rite Aid stores in California were selling over 200 expired items, including baby formula and condoms. Similar violations were identified in 132 stores in West Virginia, prompting the state's Attorney General to prepare legal action. Following media exposure, Rite Aid committed to removing all outdated merchandise.

Fraudulent Activities

In October 2018, a former vice president of advertising at Rite Aid and two co-owners of Nuvision Graphics admitted guilt in a kick-back scheme defrauding Rite Aid of $5.7 million.

Back in June 2002, the Securities and Exchange Commission charged senior Rite Aid executives with accounting fraud. CEO Martin Grass and Franklin C. Brown were accused of overstating losses by $1.6 billion over multiple years. While initially reporting profits of $541 million for fiscal years 1998 and 1999, the company later disclosed losses totaling $670.5 million in the first quarter of 2000. Prosecutors claimed Grass and Brown paid more than $11 million to settle a lawsuit filed by a former employee to prevent disclosure. Several executives, including Grass—who is the son of the founder—served prison sentences; Grass was incarcerated for six years.

In January 2003, Rite Aid reached a $10.75 million settlement with its insurers to compensate employees after allegations surfaced that the company breached fiduciary duties by permitting stock purchases based on falsified financial records. By June 2003, federal prosecutors had pressured Brown to alter his plea regarding a 35-count indictment. Eric S. Sorkin pleaded guilty to obstruction of justice for misleading investigators and faced a minimum five-year prison term along with a $250,000 fine.

Rite Aid v. Wilczynski

In May 1989, Rite Aid initiated a defamation suit against Melvin Wilczynski, a member of the state pharmacy board who was allegedly approached with a bribe from president Martin Grass. The complaint asserted that Wilczynski provided false information about Grass’s conduct to authorities. In June 1989, a federal judge barred Rite Aid from pursuing depositions and document requests until the conclusion of the criminal bribery case against Grass.

Death of Ronald S. Demorest

Ronald S. Demorest, manager at the Homewood, Pennsylvania store, was kidnapped and killed in November 1995. His parents filed a wrongful death lawsuit in March 1996 against Rite Aid and PNC Bank citing insufficient security measures. PNC Bank was removed from the case by November 1996, and by October 1997, Rite Aid was dismissed based on worker’s compensation immunity provisions.

William Ronci v. Rite Aid Corp.

In 1999, Bill Ronci, proprietor of Family Discount Drugs and Trendi's Emporium, brought legal action against Rite Aid after construction activities related to a nearby store caused roof leaks that damaged his inventory. This dispute continued for several years.

Rite Aid shareholders v. Rite Aid Corp.

In November 2000, Rite Aid resolved a class action lawsuit filed by shareholders for $45 million across courts in Philadelphia and Delaware. The settlement was financed through liability insurance proceeds and $155 million worth of company stock, enabling Rite Aid to pursue litigation against certain executives and its external auditor KPMG.

Claims of improper drug handling

In September 2002, pharmacist Keith Saylor, employed at the Barbourville, Kentucky location, raised alarms regarding improper handling of medications, noting instances where drugs arrived either frozen or excessively heated. After reporting these concerns and recording conversations with delivery personnel and management, Saylor was dismissed for refusing certain directives and recording meetings without authorization.

Charges related to fraudulent prescription submissions

On July 25, 2004, Rite Aid consented to a $7 million payment to resolve accusations of submitting fraudulent prescription claims to federal health programs.

Later, on July 14, 2022, the company agreed to a $10.5 million settlement with counties in Georgia, North Carolina, and Ohio tied to opioid-related lawsuits, thereby avoiding imminent trials involving major national pharmacy chains.

On March 14, 2023, the U.S. government filed a lawsuit against Rite Aid for neglecting to detect warning signs while unlawfully dispensing hundreds of thousands of controlled substance prescriptions—including opioids—between May 2014 and June 2019.

Hall v. Rite Aid Corporation

In the class action lawsuit concerning employee seating (Hall v. Rite Aid Corporation), the parties agreed upon an $18 million settlement alongside a two-year pilot program introducing seating at front-end checkstands. The court granted preliminary approval on September 14, 2018, followed by final approval on November 16, 2018.

In re National Prescription Opiate Litigation

Rite Aid is named as a defendant in the multidistrict litigation titled In re National Prescription Opiate Litigation, which involves claims brought by municipalities, hospitals, counties, and third-party payors regarding the consequences of opioid misuse. Plaintiffs assert that responsibility extends throughout the pharmaceutical supply chain, encompassing manufacturers, distributors, and retail pharmacy chains.

Byron Stafford v. Rite Aid Corp. and Robert Josten v. Rite Aid Corp.

In January 2019, Rite Aid revealed its participation in two consumer class action suits alleging that customers’ insurance providers were overcharged for prescription medications, resulting in inflated copay amounts.

Surveillance measures

A July 2020 Reuters report disclosed that throughout the 2010s, Rite Aid implemented facial recognition surveillance systems from providers such as FaceFirst and DeepCam across numerous U.S. stores. Cathy Langley, Vice President of asset protection, described this technology as “feature matching,” attributing it to reductions in violence and organized criminal activities. Former VP Bob Oberosler emphasized enhancements in employee safety and decreased reliance on law enforcement. In 2020, Rite Aid announced it had ceased use of facial recognition software and deactivated associated cameras.

According to Read Hayes from the National Retail Federation Loss Prevention Research Council, Rite Aid’s deployment constituted one of the largest retail applications of facial recognition technology. Other retailers including The Home Depot, Menards, Walmart, and 7-Eleven also ran pilot programs during this timeframe.

Locations situated in communities with predominantly people of color were found to be three times more likely to have this technology installed, raising concerns about potential racial profiling. Rite Aid responded that site selection was “data-driven,” relying on theft records, crime statistics, and existing site infrastructure.

Customer loyalty and rewards programs

Rite Aid introduced the Wellness+ card as a complimentary shopping rewards initiative nationwide on April 18, 2010. In May 2015, this program was integrated with the Plenti rewards platform, supported by American Express, allowing shoppers to accumulate Plenti points with every purchase. Prior to Plenti's discontinuation in July 2018, Rite Aid revived its Wellness+ program on January 1, 2018, providing customers with Wellness+ BonusCash that could be redeemed at its stores.

The company terminated all rewards programs on June 5, 2025, coinciding with its shutdown and second bankruptcy filing.

Partnerships

In January 1999, Rite Aid formed a collaboration with General Nutrition Centers (GNC) to establish GNC-branded outlets within roughly 1,500 Rite Aid stores. That same year, a partnership with Drugstore.com enabled customers to order prescriptions online and pick them up the same day in-store.

Amazon introduced its Counter pick-up service at more than 100 Rite Aid locations across the country in June 2019, permitting Amazon customers to retrieve their purchases at designated counters inside the stores.

In May 2022, Rite Aid teamed up with Homeward, a rural home care startup, to offer Medicare-eligible clients access to Homeward’s clinical services and mobile care units at selected pharmacy sites.

External links

• Official website (Archive)